<DOC>
	<DOCNO>NCT02214277</DOCNO>
	<brief_summary>The Sentinel System safe effective method capture remove embolic material ( thrombus/debris ) transcatheter aortic valve replacement order reduce ischemic burden cerebral anterior circulation .</brief_summary>
	<brief_title>Cerebral Protection Transcatheter Aortic Valve Replacement</brief_title>
	<detailed_description>The Sentinel™ Cerebral Protection System indicate use embolic capture retrieval system intend reduce ischemic burden cerebral anterior circulation perform transcatheter aortic valve replacement . The objective study ass safety efficacy Claret Medical Sentinel Cerebral Protection System use embolic protection Transcatheter Aortic Valve Replacement ( TAVR ) compare TAVR standard care ( without embolic protection ) . The study population comprise subject severe symptomatic calcify native aortic valve stenosis meet commercially approve indication TAVR Edwards SAPIEN THV SAPIEN XT comply inclusion/exclusion criterion .</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1 . Approved indication commercially available Edwards SAPIEN Transcatheter Heart Valve , model 9000TFX SAPIEN XT , model 9300TFX meeting one three subcriteria : SAPIEN 1. transfemoral delivery subject severe symptomatic calcify native aortic valve stenosis without severe aortic insufficiency ejection fraction &gt; 20 % examined heart team include experienced cardiac surgeon cardiologist find either : 1. inoperable exist comorbidities would preclude expected benefit correction aortic stenosis ; 2. operative candidate aortic valve replacement Society Thoracic Surgeons predict operative risk score &gt; 8 % judged heart team 15 % risk mortality surgical aortic valve replacement . 2. transapical delivery subject severe symptomatic calcify native aortic valve stenosis without severe aortic insufficiency ejection fraction &gt; 20 % examined heart team include experienced cardiac surgeon cardiologist find operative candidate aortic valve replacement Society Thoracic Surgeons operative risk score 8 % judged heart team 15 % risk mortality surgical aortic valve replacement . SAPIEN XT ( Transfemoral Transapical ) 3. patient symptomatic heart disease due severe native calcific aortic stenosis ( aortic valve area ≤ 1.0 cm2 aortic valve area index ≤ 0.6 cm2/m2 , mean aortic valve gradient ≥ 40 mmHg , peak aorticjet velocity ≥ 4.0 m/s ) , native anatomy appropriate 23 , 26 , 29 mm valve system , judge heart team , include cardiac surgeon , high great risk open surgical therapy ( i.e. , Society Thoracic Surgeons operative risk score ≥8 % ≥15 % risk mortality 30 day ) . 2 . Compatible left common carotid artery ( 6.5 10 mm ) brachiocephalic artery ( 9 15 mm ) diameter without significant stenosis ( &gt; 70 % ) determine MultiSlice Computed Tomography ( MSCT ) scan equivalent image modality 3 . The subject treating physician agree subject return require postprocedure followup visit 4 . The subject subject 's legal representative inform nature trial , agree provision provide write informed consent approve IRB respective clinical site General 1 . Vasculature right extremity preclude 6Fr sheath radial brachial access 2 . Inadequate circulation right extremity evidence sign artery occlusion ( modify Allen 's test ) absence radial/brachial pulse 3 . Hemodialysis shunt , graft , arteriovenous fistula involve upper extremity vasculature 4 . Evidence acute myocardial infarction ≤ 1 month intend treatment 5 . Aortic valve congenital unicuspid bicuspid valve ; noncalcified 6 . Mixed aortic valve disease ( aortic stenosis aortic regurgitation predominant aortic regurgitation &gt; 3+ ) 7 . Any therapeutic invasive cardiac procedure result permanent implant perform within 30 day index procedure ( unless part plan strategy treatment concomitant coronary artery disease ) 8 . Preexisting prosthetic heart valve position , prosthetic ring , severe ( great 3+ ) mitral insufficiency 9 . Blood dyscrasia define : Leukopenia , acute anemia , thrombocytopenia , history bleed diathesis coagulopathy 10 . Hemodynamic instability require inotropic support mechanical heart assistance . 11 . Need emergency surgery reason 12 . Hypertrophic cardiomyopathy without obstruction 13 . Severe ventricular dysfunction LVEF ≤20 % 14 . Echocardiographic evidence intracardiac aortic mass , thrombus , vegetation 15 . Symptomatic asymptomatic severe occlusive carotid disease require concomitant CEA/stenting 16 . Subject undergone carotid stenting carotid endarterectomy within previous 6 week 17 . Active peptic ulcer upper GI bleeding within prior 3 month 18 . A known hypersensitivity contraindication aspirin , heparin , ticlopidine , clopidogrel , sensitivity contrast medium , adequately premedicated 19 . Recent ( within 6 month ) CVA TIA 20 . Renal insufficiency ( creatinine &gt; 3.0 mg/dL GFR &lt; 30 ) and/or renal replacement therapy time screen 21 . Life expectancy &lt; 12 month due noncardiac comorbid condition 22 . Subjects antiplatelet and/or anticoagulant therapy contraindicate , refuse transfusion 23 . Subjects active bacterial endocarditis active infection 24 . Currently participate investigational drug another device study 25 . Subjects plan treatment investigational device procedure study followup period ( 90 day ) 26 . Subject plan concomitant surgical transcatheter ablation Atrial Fibrillation study followup period ( 90 day ) 27 . Any subject balloon valvuloplasty ( BAV ) within 30 day procedure Neurologic 28 . Subject active major psychiatric disease 29 . Subject severe visual , auditory , learn impairment unable comprehend English therefore unable consent study 30 . Subjects neurodegenerative progressive neurological disease history significant head trauma follow persistent neurologic default know structural brain abnormality Angiographic 31 . Excessive tortuosity right radial/brachial/subclavian artery prevent Sentinel System access insertion 32 . Subject whose brachiocephalic leave carotid artery reveals significant stenosis , calcification , ectasia , dissection , aneurysm ostium within 3 cm ostium Magnetic Resonance Imaging 33 . Subject Body Mass Index ( BMI ) preclude image scanner 34 . Contraindications MRI ( subject implantable temporary permanent pacemaker defibrillator , metal implant field view , metallic fragment , clip , device brain eye TAVR procedure ) 35 . Planned implantation pacemaker defibrillator implantation TAVR 36 . Claustrophobia 37 . Known allergy gadolinium contrast agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Embolic Protection</keyword>
	<keyword>Edwards SAPIEN THV</keyword>
	<keyword>Edwards SAPIEN XT</keyword>
	<keyword>TAVR</keyword>
	<keyword>Transfemoral</keyword>
	<keyword>Transapical</keyword>
	<keyword>Heart Valve Diseases</keyword>
	<keyword>Heart Diseases</keyword>
	<keyword>TAVI</keyword>
	<keyword>Aortic Stenosis</keyword>
	<keyword>Aortic Valve</keyword>
	<keyword>Transcatheter Heart Valve</keyword>
</DOC>